Literature DB >> 18295703

Radiofrequency ablation in combination with osteoplasty in the treatment of painful metastatic bone disease.

Ralf Thorsten Hoffmann1, Tobias F Jakobs, Christoph Trumm, Christof Weber, Thomas K Helmberger, Maximilian F Reiser.   

Abstract

PURPOSE: To evaluate the feasibility and effectiveness of combining radiofrequency (RF) ablation and osteoplasty for pain reduction in the treatment of painful osteolytic metastases.
MATERIALS AND METHODS: Within 5 years, 22 patients (15 men and seven women; median age, 64 years) with 28 lesions located in the thoracic and lumbar spine, sacrum, pelvis, acetabulum, femur, and tibia were treated. Underlying tumors were breast, lung, renal cell, thyroid, cancer of unknown primary, and multiple myeloma. RF ablation was performed with the patient under moderate sedation and computed tomographic fluoroscopy guidance and was immediately followed by cement injection. Pain relief was evaluated with the visual analogue scale (VAS) score and the extent to which analgesics could be reduced. Clinical success was defined as a substantial reduction in pain and/or a reduced demand for analgesics, and technical success was defined as distribution of cement between both endplates of a vertebral body or at least 75% filling of osteolyses in other bones.
RESULTS: Technical success and pain relief was achieved in all patients. Pain ratings with the VAS decreased from a mean of 8.5 to a mean of 5.5 after 24 hours (P < .01), and a further decrease was detected after 3 months to 3.5 (P < .01). The amount or strength of analgesics was reduced in 15 patients and remained unchanged in five. In two patients, the amount of analgesics increased due to tumor progression elsewhere. No major complication, no clinically obvious fracture of a formerly treated bone or treatment-related death, occurred.
CONCLUSIONS: RF ablation and osteoplasty can be combined within one session and is both feasible and useful for the treatment of osteolytic bone metastases with regard to pain relief.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295703     DOI: 10.1016/j.jvir.2007.09.016

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  33 in total

Review 1.  Interventional MSK procedures: the hip.

Authors:  Emilie Dodré; Guillaume Lefebvre; Eric Cockenpot; Patrick Chastanet; Anne Cotten
Journal:  Br J Radiol       Date:  2015-09-23       Impact factor: 3.039

2.  Osteoplasty: Percutaneous Bone Cement Injection beyond the Spine.

Authors:  Giovanni Carlo Anselmetti
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

Review 3.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

Review 4.  Combined Vertebral Augmentation and Radiofrequency Ablation in the Management of Spinal Metastases: an Update.

Authors:  Ning Mao Kam; Julian Maingard; Hong Kuan Kok; Dinesh Ranatunga; Duncan Brooks; William C Torreggiani; Peter L Munk; Michael J Lee; Ronil V Chandra; Hamed Asadi
Journal:  Curr Treat Options Oncol       Date:  2017-11-16

5.  Combination radiofrequency ablation and cementoplasty for palliative treatment of painful neoplastic bone metastasis: experience with 53 treated lesions in 36 patients.

Authors:  Michael David Lane; Huy B Q Le; Steven Lee; Casey Young; Manraj K S Heran; Maziar Badii; Paul William Clarkson; Peter L Munk
Journal:  Skeletal Radiol       Date:  2010-08-05       Impact factor: 2.199

6.  [Three-dimensional fluoroscopy-based navigation with the VBS® cage for defect augmentation of the pelvis due to metastatic tumor treated].

Authors:  A Rübberdt; W Begemann
Journal:  Unfallchirurg       Date:  2013-05       Impact factor: 1.000

7.  Bone radiofrequency ablation combined with prophylactic internal fixation for metastatic bone tumor of the femur from hepatocellular carcinoma.

Authors:  Koichi Ogura; Ryoko Miyake; Shuichiro Shiina; Yusuke Shinoda; Tomotake Okuma; Hiroshi Kobayashi; Takahiro Goto; Kozo Nakamura; Hirotaka Kawano
Journal:  Int J Clin Oncol       Date:  2011-09-15       Impact factor: 3.402

8.  Percutaneous imaging-guided ablation therapies in the treatment of symptomatic bone metastases: preliminary experience.

Authors:  G Carrafiello; D Laganà; C Pellegrino; F Fontana; M Mangini; P Nicotera; M Petullà; E Bracchi; E Genovese; S Cuffari; C Fugazzola
Journal:  Radiol Med       Date:  2009-05-14       Impact factor: 3.469

9.  Percutaneous osteoplasty for painful sternal lesion from multiple myeloma.

Authors:  Bing Zhou; Chun-Gen Wu; Ming-Hua Li; Yi-Feng Gu; Yong-De Cheng
Journal:  Skeletal Radiol       Date:  2008-12-03       Impact factor: 2.199

10.  Successful management of bulky osseous metastasis of renal cell carcinoma with selective arterial embolization and radiofrequency ablation: a case report.

Authors:  Christos Emmanouilides; Danai Chourmouzi; Ioannis Dedes; Dimitrios Pantoleon; Polikseni Mantziari; Antonios Drevelengas
Journal:  Cases J       Date:  2009-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.